跳至主要内容
临床试验/CTRI/2024/03/063560
CTRI/2024/03/063560尚未招募Unknown

Prevalence and association of microsatellite instability and Lynch syndrome pan-cancer and development of a personalised cancer risk prediction tool for Lynch syndrome carriers in India - NI

Foundation for Research in Genetics and Endocrinology0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • In order to be eligible to participate in this study, patient must meet all of the following criteria:
  • (a)Patient has recently been diagnosed with a primary cancer or FFPE treated primary tumour biopsy is available from the archive for one of the following anatomical sites- small intestine, stomach, oesophagus, liver, pancreas and endometrium.
  • (b)Patient must be alive at the time of tumour and whole blood sample collection.
  • (c)First degree relatives of Lynch syndrome carriers with or without prior history of cancer are eligible to participate in the study.
  • (d)All patients must sign an informed consent for participating in the study and undergoing whole exome sequencing.

排除标准

  • A potential patient who meets any of the above inclusion criteria will be excluded from participation in this study if there is:
  • (a) Unavailability of tumour or matched blood sample
  • (b) A language barrier to understanding the procedure
  • (c) No signed informed consent.

研究者

发起方
Foundation for Research in Genetics and Endocrinology

相似试验

Prevalence of common hereditary cancer syndrome-... | 临床试验